Family guy, physician scientist and open water swimmer who enjoys being at the core of precision med. to improve clinical outcomes through molecular diagnostics
Today, we are thrilled to share the news that Palmetto GBA’s Molecular Diagnostic Services Program (MolDX) Program issued a positive coverage decision for the Pathlight MRD test.
Read more here https://t.co/sOnMMVab6Z
📌15 Posts Not to Miss from the 3rd Day of @ASCO 2025
The ASCO Annual Meeting 2025 is officially underway in Chicago! Running from May 30 to June 3, this year’s meeting brings together oncologists, researchers, and advocates worldwide to share the latest breakthroughs in cancer care.
This year’s theme, “Driving Knowledge to Action: Building a Better Future,” sets the tone for what ASCO 2025 is all about, turning research into real impact for patients. Visit the link to dive into the science, and hear directly from the people shaping the future of cancer care: https://t.co/lrdh5PPfBA
@ASCOPres@fabiomoraesmd@pashtoonkasi@DanielSumarriva@VivekSubbiah@ICR_London@ArmandOrlandi@RoupenMD@Dr_ElvinaA@NehemiasGuevar5@GlopesMd@nataliagandur
#OncoDaily #Oncology #Cancer #Health #Medicine #ASCO25 #ASCO2025
Caris Life Sciences is proud to announce that it has published more than 1,000 studies across peer-reviewed manuscripts, posters, and abstracts since 2015, in collaboration with its research partners. Learn more: https://t.co/kd57lt1uwH
MI Cancer Seek™ is now available for clinical ordering. The first and only simultaneous WES/WTS-based assay with CDx indications for adult and pediatric patients. Read more about MI Cancer Seek and view important product information. https://t.co/OP0FGpvff6
MI Cancer Seek™ is now available. The first and only simultaneous WES/WTS-based assay with CDx indications for adult and pediatric patients. Read more
about MI Cancer Seek and view important product information. https://t.co/GiSBusZkOi #precisionmedicine
Caris announces a strategic collaboration with @OntadaOncology to drive next-gen therapeutic development and advance cancer care. Learn more:
https://t.co/31wdgxg07b
MI Cancer Seek™, the first and only simultaneous WES/WTS-based assay with FDA-approved CDx indications for molecular profiling of solid tumors for both adult and pediatric patients. Read more about MI Cancer Seek and view important product information: https://t.co/fbNfjwEeyF
Great collaboration with Amazon Web Services (@awscloud) to accelerate research and enhance patient care through efficient data processing.
https://t.co/mVZ5wTJ0MK